Kelun Pharmaceutical (SZ002422onlinepokernodepositbonus, latest price: 34onlinepokernodepositbonus.97 yuan) issued an announcement stating that on May 13, 2024, 15:00-16:00. Kelun Pharmaceutical held a performance briefing meeting. Chairman Liu Xinxin, independent director Gao Jinbo, deputy general manager Ge Tao, deputy general manager Ding Nanchao, deputy general manager and financial director Lai Degui, deputy general manager and secretary of the board of directors Feng Hao, Kelun Botai Chief Financial Officer and Secretary of the Board of Directors Zhou Zejian, deputy general manager and Secretary of the Board of Directors Gu Xiang, and Changjiang Securities Sponsored Representative Yang Guangyuan attended the briefing and answered questions raised by the research institutions.
From January to December 2023, Kelun Pharmaceutical's operating income is composed of: pharmaceutical manufacturing accounted for 89.34%, R & D projects accounted for 7.22%, and others accounted for 3.45%.
(Article source: Daily Economic News)
